Case series: CYP Inhibition and low dose ibrutinib for steroid-refractory chronic graft-versus-host disease

被引：1
|
作者：
De la Garza-Salazar, Fernando
Colunga-Pedraza, Perla Rocio
Coronado-Alejandro, Edgar Ulises
Gutierrez-Aguirre, Cesar Homero
Cantu-Rodriguez, Olga Graciela
Gomez-Almaguer, David [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Hematol Serv, Internal Med Dept, Monterrey, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷 / 03期
关键词：
chronic graft versus host disease; CYP; ibrutinib; itraconazole; low dose;
D O I：
10.1111/bjh.18712
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：573 / 576
页数：4
相关论文
共 50 条
  • [1] Low-dose rituximab in steroid-refractory chronic graft-versus-host disease
    Colunga-Pedraza, Perla R.
    Barbosa-Castillo, Luz Maria
    Coronado-Alejandro, Edgar Ulises
    Vaquera-Alfaro, Hector Alejandro
    Lopez-Reyna, Ingrid Gabriela
    Colunga-Pedraza, Julia E.
    Gomez-Almaguer, David
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [2] Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
    Chin, Kuo-Kai
    Kim, Haesook T.
    Inyang, Eno-Abasi
    Ho, Vincent
    Koreth, John
    Romee, Rizwan
    Gooptu, Mahasweta
    Shapiro, Roman
    Antin, Joseph
    Soiffer, Robert
    Jaglowski, Samantha
    Pidala, Joseph
    Cutler, Corey
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 990.e1 - 990.e7
  • [3] Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
    von Bonin, Malte
    Oelschlaegel, Uta
    Radke, Joergen
    Stewart, Michelle
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    TRANSPLANTATION, 2008, 86 (06) : 875 - 879
  • [4] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
  • [5] Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study
    Dal Sinan, Mehmet
    Batgi, Hikmettullah
    Erkurt, Mehmet Ali
    Hindilerden, Ipek Yonal
    Kuku, Irfan
    Kurtoglu, Erdal
    Kaya, Emin
    Besisik, Sevgi Kalayoglu
    Berber, Ilhami
    Nalcaci, Meliha
    Ulas, Turgay
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (05)
  • [6] Retrospective Multicenter Study of Extracorporeal Photopheresis in Steroid-Refractory Acute and Chronic Graft-versus-Host Disease
    Oarbeascoa, Gillen
    Luisa Lozano, Maria
    Maria Guerra, Luisa
    Amunarriz, Cristina
    Andon Saavedra, Concepcion
    Garcia-Gala, Jose Maria
    Viejo, Aurora
    Revilla, Nuria
    Acosta Fleitas, Cynthia
    Luis Arroyo, Jose
    Martinez Revuelta, Eva
    Galego, Andrea
    Hernandez-Maraver, Dolores
    Kwon, Mi
    Luis Diez-Martin, Jose
    Pascual, Cristina
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : 651 - 658
  • [7] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Jiapei Liu
    Zhiping Fan
    Na Xu
    Jieyu Ye
    Yanqiu Chen
    Ruoyang Shao
    Yiming Sun
    Qiaoyuan Wu
    Qifa Liu
    Hua Jin
    Annals of Hematology, 2023, 102 : 2865 - 2877
  • [8] Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
    Liu, Jiapei
    Fan, Zhiping
    Xu, Na
    Ye, Jieyu
    Chen, Yanqiu
    Shao, Ruoyang
    Sun, Yiming
    Wu, Qiaoyuan
    Liu, Qifa
    Jin, Hua
    ANNALS OF HEMATOLOGY, 2023, 102 (10) : 2865 - 2877
  • [9] Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
    Kim, Haesook T.
    Koreth, John
    Whangbo, Jennifer
    Nikiforow, Sarah
    Reynolds, Carol G.
    Stowe, Peter
    Ho, Vincent T.
    Cutler, Corey
    Antin, Joseph H.
    Soiffer, Robert J.
    Ritz, Jerome
    BLOOD ADVANCES, 2022, 6 (15) : 4392 - 4402
  • [10] Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience
    Xue, Elisabetta
    Lorentino, Francesca
    Pavesi, Francesca
    Assanelli, Andrea
    Peccatori, Jacopo
    Bernardi, Massimo
    Corti, Consuelo
    Ciceri, Fabio
    Stanghellini, Maria Teresa Lupo
    LEUKEMIA RESEARCH, 2021, 109
12345